Ainos, Inc. (AIMDW) stock
Close on Oct 30, 2026Market cap $4.64MP/E –Yield –
Ainos, Inc. saw revenue fall 87.7% to $13.60K over the twelve months to Jun 30, 2026. Free cash flow was -$4.49M. At the latest close the market valued the company at $4.64M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.64M
- P/E ratio
- –
- Price to sales
- 341.30
- Price to book
- 1.41
- Dividend yield
- –
- Free cash flow yield
- -96.83%
Fundamentals
- Revenue
- $13.60K
- Net income
- -$14.45M
- EPS, diluted
- -$2.53
- Free cash flow
- -$4.49M
- Book value per share
- $0.45
- Diluted shares
- 7M
Trading
- Next earnings
- Nov 12, 2026 (estimated, after the close)
- Previous close
- $0.03
- Open
- $0.03
- Day's range
- $0.03 – $0.03
- Average volume (20 days)
- 9,106
- Beta (5 years)
- 2.48
- 52-week range
- $0.56 – $3.88
- RSI (14 days)
- 15.5
- Volatility (1 year)
- 138.8%
- Relative volume
- 0.21×
- WACC
- 17.4%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | AIMDW | S&P 500 | Difference | AIMDW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -65.3% | -0.9% | −64.4 pts | ||
| 3 months | -73.6% | +2.1% | −75.8 pts | ||
| Year to date | -75.2% | +11.7% | −86.9 pts | ||
| 1 year | -74.6% | +12.4% | −86.9 pts | ||
| 3 years | -93.5% | +88.6% | −182.1 pts | -59.8% | +23.5% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Ainos filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Results
- Results
- Results
- Results
About Ainos
Computer Peripheral Equipment, NEC
Ainos, Inc. is a technology and healthcare company that specializes in artificial intelligence-powered scent digitization and immune therapeutics. Its flagship technology, AI Nose, utilizes gas sensor arrays and a proprietary smell language model to convert scent and volatile organic compound signals into digital data for real-time detection, analysis, and environmental monitoring. Initially created for healthcare use cases such as point-of-care testing and infection monitoring, the platform also targets industrial applications, including semiconductor manufacturing, robotics, and smart production facilities. The company operates a subsidiary, ScentAI Inc., dedicated to algorithm development, and additionally develops low-dose oral interferon therapies under its VELDONA platform for rare, autoimmune, and infectious diseases, alongside commercial pet supplements.
Company profile, executives and historyAinos stock: common questions
What is Ainos's stock price?
AIMDW closed at $0.03 on Oct 30, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $0.56 and $3.88.
What is Ainos's market cap?
Ainos was worth $4.64M at the close on Oct 30, 2026: the share price times the diluted shares outstanding.
What is AIMDW's P/E ratio?
Ainos lost money over the twelve months to Jun 30, 2026 (diluted EPS -$2.53), so it has no meaningful P/E ratio.
How much revenue does Ainos make?
Ainos reported revenue of $13.60K for the twelve months to Jun 30, 2026, down 87.7% from a year earlier.
Does Ainos pay a dividend?
No. Ainos has not paid a cash dividend over the last twelve months.
When does Ainos report earnings next?
Ainos is expected to report Q3 FY2026 results on Nov 12, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has AIMDW stock performed over the past year?
Including dividends, AIMDW returned -74.6% over the past year, against +12.4% for the S&P 500.
Who are Ainos's competitors?
Companies most similar to Ainos by business, industry and size include GIPL, ADTX, VRAX, PRFX, IBO.